A randomized study of the immunogenicity and safety of Japanese Encephalitis Chimeric Virus Vaccine (JE-CV) in comparison with SA14-14-2 Vaccine in children in the Republic of Korea

References

• Halstead SB, Thomas SJ. Japanese encephalitis: new options for active immunization. Clin Infect Dis 2010; 50:1155-64; PMID:20218889; http://dx.doi.org/10.1086/651271
   PubMed Web of Science ®Google Scholar
• Fischer M, Lindsey N, Staples JE, Hills S; Centers for Disease Control and Prevention (CDC). Japanese encephalitis vaccines: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 2010; 59(RR-1):1-27; PMID:20224546
   PubMedGoogle Scholar
• Halstead SB, Tsai TF. Japanese Encephalitis Vaccines. In: Plotkin SA, Orenstein WA, Editors.Vaccines. 4th ed. PA, USA; 2003. p. 919-58.
   Google Scholar
• WHO Position Paper on Japanese Encephalitis Vaccines. Completion of a national laboratory inventory for wild poliovirus containment, WHO European Region, June 2006. Wkly Epidemiol Rec 2006; 81:325-8; PMID:16933378
   PubMedGoogle Scholar
• Solomon T, Thao TT, Lewthwaite P, Ooi MH, Kneen R, Dung NM, White N. A cohort study to assess the new WHO Japanese encephalitis surveillance standards. Bull World Health Organ 2008; 86:178-86; PMID:18368204; http://dx.doi.org/10.2471/BLT.07.043307
   PubMed Web of Science ®Google Scholar
• Choe YJ, Yang JJ, Park SK, Choi EH, Lee HJ. Comparative estimation of coverage between national immunization program vaccines and non-NIP vaccines in Korea. J Korean Med Sci 2013; 28:1283-8; PMID:24015031; http://dx.doi.org/10.3346/jkms.2013.28.9.1283
   PubMed Web of Science ®Google Scholar
• Barban V, Girerd Y, Aguirre M, Gulia S, Pétiard F, Riou P, Barrere B, Lang J. High stability of yellow fever 17D-204 vaccine: a 12-year restrospective analysis of large-scale production. Vaccine 2007; 25:2941-50; PMID:16914238; http://dx.doi.org/10.1016/j.vaccine.2006.06.082
   PubMed Web of Science ®Google Scholar
• Chambers TJ, Nestorowicz A, Mason PW, Rice CM. Yellow fever/Japanese encephalitis chimeric viruses: construction and biological properties. J Virol 1999; 73:3095-101; PMID:10074160
   PubMed Web of Science ®Google Scholar
• Guirakhoo F, Zhang ZX, Chambers TJ, Delagrave S, Arroyo J, Barrett AD, Monath TP. Immunogenicity, genetic stability, and protective efficacy of a recombinant, chimeric yellow fever-Japanese encephalitis virus (ChimeriVax-JE) as a live, attenuated vaccine candidate against Japanese encephalitis. Virology 1999; 257:363-72; PMID:10329547; http://dx.doi.org/10.1006/viro.1999.9695
   PubMed Web of Science ®Google Scholar
• Torresi J, McCarthy K, Feroldi E, Méric C. Immunogenicity, safety and tolerability in adults of a new single-dose, live-attenuated vaccine against Japanese encephalitis: Randomised controlled phase 3 trials. Vaccine 2010; 28:7993-8000; PMID:20934459; http://dx.doi.org/10.1016/j.vaccine.2010.09.035
   PubMed Web of Science ®Google Scholar
• Chokephaibulkit K, Sirivichayakul C, Thisyakorn U, Sabchareon A, Pancharoen C, Bouckenooghe A, Gailhardou S, Boaz M, Feroldi E. Safety and immunogenicity of a single administration of live-attenuated Japanese encephalitis vaccine in previously primed 2- to 5-year-olds and naive 12- to 24-month-olds: multicenter randomized controlled trial. Pediatr Infect Dis J 2010; 29:1111-7; PMID:20856164; http://dx.doi.org/10.1097/INF.0b013e3181f68e9c
   PubMed Web of Science ®Google Scholar
• Feroldi E, Pancharoen C, Kosalaraksa P, Watanaveeradej V, Phirangkul K, Capeding MR, Boaz M, Gailhardou S, Bouckenooghe A. Single-dose, live-attenuated Japanese encephalitis vaccine in children aged 12-18 months: randomized, controlled phase 3 immunogenicity and safety trial. Hum Vaccin Immunother 2012; 8:929-37; PMID:22777096; http://dx.doi.org/10.4161/hv.20071
   PubMed Web of Science ®Google Scholar
• Feroldi E, Capeding MR, Boaz M, Gailhardou S, Meric C, Bouckenooghe A. Memory immune response and safety of a booster dose of Japanese encephalitis chimeric virus vaccine (JE-CV) in JE-CV-primed children. Hum Vaccin Immunother 2013; 9:889-97; PMID:23442823; http://dx.doi.org/10.4161/hv.23087
   PubMed Web of Science ®Google Scholar
• Feroldi E, Pancharoen C, Kosalaraksa P, Chokephaibulkit K, Boaz M, Meric C, Hutagalung Y, Bouckenooghe A. Primary immunization of infants and toddlers in Thailand with Japanese encephalitis chimeric virus vaccine in comparison with SA14-14-2: a randomized study of immunogenicity and safety. Pediatr Infect Dis J 2014; 33:643-9; PMID:24717964; http://dx.doi.org/10.1097/INF.0000000000000276
   PubMed Web of Science ®Google Scholar
• Hombach J, Solomon T, Kurane I, Jacobson J, Wood D. Report on a WHO consultation on immunological endpoints for evaluation of new Japanese encephalitis vaccines, WHO, Geneva, 2-3 September, 2004. Vaccine 2005; 23:5205-11; PMID:16055233; http://dx.doi.org/10.1016/j.vaccine.2005.07.002
   PubMed Web of Science ®Google Scholar
• Van Gessel Y, Klade CS, Putnak R, Formica A, Krasaesub S, Spruth M, Cena B, Tungtaeng A, Gettayacamin M, Dewasthaly S. Correlation of protection against Japanese encephalitis virus and JE vaccine (IXIARO(®)) induced neutralizing antibody titers. Vaccine 2011; 29:5925-31; PMID:21723353; http://dx.doi.org/10.1016/j.vaccine.2011.06.062
   PubMed Web of Science ®Google Scholar
• Bonaparte M, Dweik B, Feroldi E, Meric C, Bouckenooghe A, Hildreth S, Hu B, Yoksan S, Boaz M. Immune response to live-attenuated Japanese encephalitis vaccine (JE-CV) neutralizes Japanese encephalitis virus isolates from south-east Asia and India. BMC Infect Dis 2014; 14:156; PMID:24656175; http://dx.doi.org/10.1186/1471-2334-14-156
   PubMed Web of Science ®Google Scholar
• Lee DW, Choe YJ, Kim JH, Song KM, Cho H, Bae GR, Lee JK. Epidemiology of Japanese encephalitis in South Korea, 2007-2010. Int J Infect Dis 2012; 16:e448-52; PMID:22497964; http://dx.doi.org/10.1016/j.ijid.2012.02.006
   PubMed Web of Science ®Google Scholar
• Farrington CP, Manning G. Test statistics and sample size formulae for comparative binomial trials with null hypothesis of non-zero risk difference or non-unity relative risk. Stat Med 1990; 9:1447-54; PMID:2281232; http://dx.doi.org/10.1002/sim.4780091208
   PubMed Web of Science ®Google Scholar
• Newcombe RG. Interval estimation for the difference between independent proportions: comparison of eleven methods. Stat Med 1998; 17:873-90; PMID:9595617; http://dx.doi.org/10.1002/(SICI)1097-0258(19980430)17: 8<873::AID-SIM779>3.0.CO;2-I
   PubMed Web of Science ®Google Scholar
• Newcombe RG. Two-sided confidence intervals for the single proportion: comparison of seven methods. Stat Med 1998; 17:857-72; PMID:9595616; http://dx.doi.org/10.1002/(SICI)1097-0258(19980430)17: 8<857::AID-SIM777>3.0.CO;2-E
   PubMed Web of Science ®Google Scholar